657 related articles for article (PubMed ID: 16382303)
1. Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes.
Leonard BL; Watson RN; Loomes KM; Phillips AR; Cooper GJ
Acta Diabetol; 2005 Dec; 42(4):162-70. PubMed ID: 16382303
[TBL] [Abstract][Full Text] [Related]
2. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
3. Defect in glucokinase translocation in Zucker diabetic fatty rats.
Fujimoto Y; Donahue EP; Shiota M
Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E414-23. PubMed ID: 15138155
[TBL] [Abstract][Full Text] [Related]
4. Skeletal muscle contraction stimulates capillary recruitment and glucose uptake in insulin-resistant obese Zucker rats.
Wheatley CM; Rattigan S; Richards SM; Barrett EJ; Clark MG
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E804-9. PubMed ID: 15213062
[TBL] [Abstract][Full Text] [Related]
5. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
[TBL] [Abstract][Full Text] [Related]
6. Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure.
Goh TT; Mason TM; Gupta N; So A; Lam TK; Lam L; Lewis GF; Mari A; Giacca A
Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E549-60. PubMed ID: 17003242
[TBL] [Abstract][Full Text] [Related]
7. Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats.
Henriksen EJ; Kinnick TR; Teachey MK; O'Keefe MP; Ring D; Johnson KW; Harrison SD
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E892-900. PubMed ID: 12517738
[TBL] [Abstract][Full Text] [Related]
8. Analysis of gene expression profiles in insulin-sensitive tissues from pre-diabetic and diabetic Zucker diabetic fatty rats.
Suh YH; Kim Y; Bang JH; Choi KS; Lee JW; Kim WH; Oh TJ; An S; Jung MH
J Mol Endocrinol; 2005 Apr; 34(2):299-315. PubMed ID: 15821098
[TBL] [Abstract][Full Text] [Related]
9. Muscle type-specific fatty acid metabolism in insulin resistance: an integrated in vivo study in Zucker diabetic fatty rats.
Beha A; Juretschke HP; Kuhlmann J; Neumann-Haefelin C; Belz U; Gerl M; Kramer W; Roden M; Herling AW
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E989-97. PubMed ID: 16380389
[TBL] [Abstract][Full Text] [Related]
10. Endothelin antagonism improves hepatic insulin sensitivity associated with insulin signaling in Zucker fatty rats.
Berthiaume N; Carlson CJ; Rondinone CM; Zinker BA
Metabolism; 2005 Nov; 54(11):1515-23. PubMed ID: 16253642
[TBL] [Abstract][Full Text] [Related]
11. Effect of adrenalectomy on in vivo glucose metabolism in insulin resistant Zucker obese rats.
Freedman MR; Stern JS; Reaven GM; Mondon CE
Horm Metab Res; 1986 May; 18(5):296-8. PubMed ID: 3522389
[TBL] [Abstract][Full Text] [Related]
12. Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study.
Welch MJ; Lewis JS; Kim J; Sharp TL; Dence CS; Gropler RJ; Herrero P
J Nucl Med; 2006 Apr; 47(4):689-97. PubMed ID: 16595504
[TBL] [Abstract][Full Text] [Related]
13. Isomer-specific actions of conjugated linoleic acid on muscle glucose transport in the obese Zucker rat.
Henriksen EJ; Teachey MK; Taylor ZC; Jacob S; Ptock A; Krämer K; Hasselwander O
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E98-E105. PubMed ID: 12618357
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid transport and FAT/CD36 are increased in red but not in white skeletal muscle of ZDF rats.
Chabowski A; Chatham JC; Tandon NN; Calles-Escandon J; Glatz JF; Luiken JJ; Bonen A
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E675-82. PubMed ID: 16684853
[TBL] [Abstract][Full Text] [Related]
15. Effects of fasting on insulin action and glucose kinetics in lean and obese men and women.
Bergman BC; Cornier MA; Horton TJ; Bessesen DH
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1103-11. PubMed ID: 17684102
[TBL] [Abstract][Full Text] [Related]
16. Postexercise muscle triacylglycerol and glycogen metabolism in obese insulin-resistant zucker rats.
Bruce CR; Lee JS; Kiens B; Hawley JA
Obes Res; 2004 Jul; 12(7):1158-65. PubMed ID: 15292481
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated pyruvate dehydrogenase complex in Zucker diabetic fatty rats.
Schummer CM; Werner U; Tennagels N; Schmoll D; Haschke G; Juretschke HP; Patel MS; Gerl M; Kramer W; Herling AW
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E88-96. PubMed ID: 17957038
[TBL] [Abstract][Full Text] [Related]
18. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
Kruszynska YT; Olefsky JM; Frias JP
Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
[TBL] [Abstract][Full Text] [Related]
19. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia.
Smith AC; Mullen KL; Junkin KA; Nickerson J; Chabowski A; Bonen A; Dyck DJ
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E172-81. PubMed ID: 17374701
[TBL] [Abstract][Full Text] [Related]
20. Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats.
Dokken BB; Henriksen EJ
Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E207-13. PubMed ID: 16478771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]